Global Companion Animal Postoperative Pain Management Therapeutics Market Report to 2027 – Availability of Pet Insurance Presents Opportunities – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--
The "Companion Animal Postoperative Pain Management Therapeutics Market Research Report by Product (Anesthetics, NSAIDs, and Opioids), Animal Type, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Companion Animal Postoperative Pain Management Therapeutics Market size was estimated at USD 112.67 million in 2021, USD 123.68 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.94% to reach USD 199.04 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Companion Animal Postoperative Pain Management Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Companion Animal Postoperative Pain Management Therapeutics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Companion Animal Postoperative Pain Management Therapeutics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Companion Animal Postoperative Pain Management Therapeutics Market?

4. What is the competitive strategic window for opportunities in the Global Companion Animal Postoperative Pain Management Therapeutics Market?

5. What are the technology trends and regulatory frameworks in the Global Companion Animal Postoperative Pain Management Therapeutics Market?

6. What is the market share of the leading vendors in the Global Companion Animal Postoperative Pain Management Therapeutics Market?

7. What modes and strategic moves are considered suitable for entering the Global Companion Animal Postoperative Pain Management Therapeutics Market?

Market Dynamics

Drivers

• Growth in pet surgical procedures
• Rising prevalence of periodontal diseases
• Sure in companion animal ownership

Restraints

• High cost of therapeutics

Opportunities

• Rising focus and expenditure on companion animal
• Increasing availability of healthcare services and therapeutics for animals
• Availability of pet insurance

Challenges

• Limited awareness and availability in developing economies

Companies Mentioned

• Addison Biological Laboratory Inc
• Assisi Animal Health
• Bayer AG
• Bimeda Animal Health
• Boehringer Ingelheim
• Cadila Healthcare Ltd.
• Ceva Polchem
• Ceva Sante Animale
• Chanelle Pharma Group
• Daiichi Sankyo Co. Ltd.
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• K-Laser USA
• Merck Animal Health
• Norbrook Laboratories
• Novartis Animal Health
• SAVA Vet
• Vetoquinol
• Virbac Group
• Zoetis Inc.

For more information about this report visit https://www.researchandmarkets.com/r/yqwoy7

src="https://cts.businesswire.com/ct/CT?id=bwnewssty=20220517005717r1sid=acqr8distro=nxlang=en" style="width:0;height:0" />

View source version on businesswire.com: https://www.businesswire.com/news/home/20220517005717/en/

ResearchAndMarkets.com
Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Source: Research and Markets